Neovascular age-related macular degeneration (nAMD), a leading cause of vision loss among the elderly, is increasingly understood not just as an ocular condition but as a systemic aging-associated disorder. Recent insights reveal that nAMD may highlight broader vascular, inflammatory, and genetic pathways that overlap significantly with mechanisms underpinning certain cancers. This emerging perspective has profound implications for how we approach aging-related diseases more holistically.
A groundbreaking nationwide population-based study conducted in South Korea, analyzing data from over 330,000 older adults, has unveiled a nuanced link between nAMD and the risk of developing specific malignancies. Led by researchers from Konkuk University College of Medicine and Medical Center in Seoul, the investigation harnessed one of the largest population health databases globally, enabling an unprecedented longitudinal analysis over a decade. This scale provided robust statistical power to tease apart subtle but meaningful disease associations.
The researchers found that patients diagnosed with nAMD exhibited an elevated risk for several cancers—most notably thyroid, pancreatic, lung, renal, bladder, and prostate cancers. The risk increase was not uniform; rather, it was cancer-type specific, challenging prior assumptions that nAMD might simply reflect a generalized cancer susceptibility due to systemic aging. For instance, the hazard ratio for thyroid cancer was approximately 1.24, indicating a 24% higher risk among nAMD patients compared to matched controls, a finding both statistically and clinically significant.
At its core, nAMD is driven by pathological choroidal neovascularization — the growth of aberrant blood vessels beneath the retina — largely orchestrated by dysregulated vascular endothelial growth factor (VEGF) signaling. Intriguingly, many cancers also exploit VEGF-mediated angiogenesis for tumor progression. However, the complexity of the observed associations suggests that common angiogenic pathways alone cannot fully account for the cancer risk patterns seen in the nAMD population.
Delving deeper, the study points toward chronic low-grade inflammation, immunosenescence, oxidative stress, and extracellular matrix remodeling as shared biological drivers. These processes are hallmarks of aging and play pivotal roles in both retinal degeneration and oncogenesis. Cellular senescence, for example, involves the accumulation of aged cells secreting pro-inflammatory cytokines, creating a microenvironment conducive to both tissue degeneration and tumor development. Thus, the convergence of these pathological pathways may underpin the systemic vulnerability signaled by nAMD.
Moreover, genetic predispositions appear to intersect between nAMD and certain cancers. Emerging genomic analyses highlight polymorphisms within pathways related to complement activation, lipid metabolism, and extracellular matrix regulation that predispose individuals to both retinal and neoplastic diseases. This polygenic overlap hints at a shared biological vulnerability rooted in the aging process itself, transcending the boundaries of traditional organ-centric disease models.
These findings suggest that nAMD may serve as an accessible clinical marker, identifying individuals at increased systemic risk for select cancers. However, the researchers emphasize that the magnitude of increased cancer risk, while statistically significant, remains modest. Thus, nAMD should not currently prompt altered clinical cancer screening protocols in isolation. Rather, it underscores the phenotype’s potential as a sentinel of broader aging-related disease susceptibility.
The implications extend beyond epidemiology to therapeutic strategies. Multi-disease targeting approaches addressing shared pathways such as inflammation and vascular dysfunction could revolutionize care paradigms for aging populations. Interventions that modulate VEGF signaling, oxidative stress, or senescence-associated secretory phenotypes might simultaneously influence retinal health and cancer prevention or progression.
Importantly, this study illuminates the necessity of interdisciplinary collaboration bridging ophthalmology, oncology, genetics, and geroscience. Elucidating the systemic connections behind nAMD and cancer could unlock biomarker development, risk stratification tools, and personalized medicine approaches tailored to the aging individual’s broad health landscape.
Finally, this comprehensive analysis strengthens the paradigm that age-related diseases often arise from intertwined biological networks rather than isolated organ pathology. Future investigations will need to unravel causative relationships, investigate mechanistic pathways in greater molecular detail, and explore how lifestyle or pharmacological interventions could modulate these shared aging processes to improve outcomes across multiple diseases.
This nationwide study marks a critical advance in understanding how an ophthalmic diagnosis can reflect—and potentially predict—systemic vulnerability. Such insights pave the way for innovative research and ultimately improved holistic care for the growing elder population worldwide.
Subject of Research: Not applicable
Article Title: Systemic cancer risk profile in neovascular age-related macular degeneration: insights into shared aging-related mechanisms from a nationwide population-based study
News Publication Date: 22-May-2026
Web References: https://doi.org/10.18632/aging.206383
Image Credits: © 2026 Kim et al., distributed under Creative Commons Attribution License (CC BY 4.0)
Keywords: neovascular age-related macular degeneration, cancer, population cohort, polygenic risk, shared susceptibility
